Dec 05, 2017 5:00pm EST Adaptimmune Data to be Presented at American Society of Hematology (ASH) Annual Meeting Confirm NY-ESO SPEAR T-cell Efficacy in Multiple Myeloma Pilot Study
Nov 10, 2017 8:58am EST Adaptimmune Presents Study Designs for Ongoing MAGE-A4 and NY-ESO SPEAR T-cell Clinical Trials at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 09, 2017 8:00am EST NY-ESO Data Presented at the Connective Tissue Oncology Society (CTOS) Annual Meeting Confirm Potential of Adaptimmune’s SPEAR T-Cell Therapy
Nov 03, 2017 2:22pm EDT Adaptimmune to Present Two Trials in Progress Posters at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 03, 2017 2:17pm EDT Adaptimmune Data to be Presented in an Oral Presentation and a Trial in Progress Poster at the Connective Tissue Oncology Society (CTOS) Annual Meeting
Nov 02, 2017 7:30am EDT Adaptimmune Reports Third Quarter 2017 Financial Results and Business Updates
Oct 27, 2017 11:11am EDT Adaptimmune to Report Third Quarter 2017 Financial Results on November 2, 2017
Oct 23, 2017 5:51pm EDT Sébastien Desprez Joins Adaptimmune as Vice President of Communications and Investor Relations
Sep 22, 2017 10:00am EDT James Noble, Adaptimmune CEO, to Participate in Upcoming Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
